Day One Biopharmaceuticals Ownership 2024 | Who Owns Day One Biopharmaceuticals Now?
Institutional Ownership
28.18%
Insider Ownership
19.65%
Retail Ownership
52.18%
Institutional Holders
55.00
Day One Biopharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.79% | 0.19% | 7,809,852 | - | - | 129,018,755 | Mar 31, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 8.06% | 9.80% | 6,430,257 | -1,178,137 | -15.48% | 106,227,846 | Mar 31, 2024 |
| BLACKROCK INC. | 6.31% | 0.00% | 5,031,435 | -94,636 | -1.85% | 83,119,306 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.99% | 0.00% | 4,774,483 | 4,737 | 0.10% | 78,874,459 | Mar 31, 2024 |
| FMR LLC | 5.52% | 0.00% | 4,404,341 | 436,175 | 10.99% | 72,759,721 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 4.77% | 0.02% | 3,806,790 | -430,005 | -10.15% | 62,888,164 | Mar 31, 2024 |
| STATE STREET CORP | 3.63% | 0.00% | 2,894,883 | -485,215 | -14.36% | 47,823,467 | Mar 31, 2024 |
| VIKING GLOBAL INVESTORS LP | 3.21% | 0.16% | 2,558,563 | - | - | 42,267,461 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.98% | 0.04% | 2,375,137 | -196,431 | -7.64% | 39,237,263 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.88% | 0.00% | 2,299,764 | -17,000 | -0.73% | 37,993,000 | Mar 31, 2024 |
| BRAIDWELL LP | 2.72% | 1.16% | 2,173,704 | -2,041,869 | -48.44% | 35,909,590 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 2.68% | 0.01% | 2,137,491 | 18,642 | 0.88% | 35,311,351 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 2.55% | 0.02% | 2,032,384 | 336,281 | 19.83% | 33,574,983 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.21% | 0.51% | 1,765,312 | 4,134 | 0.23% | 29,162,954 | Mar 31, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 2.05% | 0.39% | 1,635,145 | -30,920 | -1.86% | 27,013,000 | Mar 31, 2024 |
| ESTUARY CAPITAL MANAGEMENT LP | 2.02% | 10.81% | 1,611,137 | 728,240 | 82.48% | 26,615,983 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.73% | 0.00% | 1,376,961 | 28,142 | 2.09% | 22,750,646 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 1.65% | 3.26% | 1,318,207 | -382,742 | -22.50% | 21,776,780 | Mar 31, 2024 |
| MAVERICK CAPITAL LTD | 1.58% | 0.39% | 1,256,570 | 1,256,570 | 100.00% | 20,758,536 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 1.49% | 0.97% | 1,189,943 | - | - | 19,657,858 | Mar 31, 2024 |
Day One Biopharmaceuticals's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 9.79% of the company's total share outstanding, currently valued at $129.02M. The top 10 institutional shareholders own together 53.13% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESTUARY CAPITAL MANAGEMENT LP | 2.02% | 10.81% | 1,611,137 | 728,240 | 82.48% | 26,615,983 | Mar 31, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 8.06% | 9.80% | 6,430,257 | -1,178,137 | -15.48% | 106,227,846 | Mar 31, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.44% | 3.82% | 349,679 | -29,947 | -7.89% | 5,776,697 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 1.65% | 3.26% | 1,318,207 | -382,742 | -22.50% | 21,776,780 | Mar 31, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 0.34% | 2.60% | 270,664 | - | - | 4,471,369 | Mar 31, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.84% | 2.51% | 666,463 | -20,000 | -2.91% | 11,009,969 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.87% | 1.40% | 691,812 | 66,063 | 10.56% | 11,428,734 | Mar 31, 2024 |
| ALTITUDE CREST PARTNERS INC. | 0.25% | 1.38% | 195,497 | 195,497 | 100.00% | 3,229,610 | Mar 31, 2024 |
| BRAIDWELL LP | 2.72% | 1.16% | 2,173,704 | -2,041,869 | -48.44% | 35,909,590 | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.62% | 1.14% | 492,627 | -20,373 | -3.97% | 8,138,198 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 1.49% | 0.97% | 1,189,943 | - | - | 19,657,858 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.45% | 0.61% | 361,767 | 58,449 | 19.27% | 5,976,391 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.21% | 0.51% | 1,765,312 | 4,134 | 0.23% | 29,162,954 | Mar 31, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.25% | 0.50% | 196,425 | - | - | 3,244,941 | Mar 31, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 2.05% | 0.39% | 1,635,145 | -30,920 | -1.86% | 27,013,000 | Mar 31, 2024 |
| MAVERICK CAPITAL LTD | 1.58% | 0.39% | 1,256,570 | 1,256,570 | 100.00% | 20,758,536 | Mar 31, 2024 |
| PFM HEALTH SCIENCES, LP | 0.45% | 0.28% | 355,251 | -948,324 | -72.75% | 5,868,747 | Mar 31, 2024 |
| SUMMIT ROCK ADVISORS, LP | 0.06% | 0.27% | 51,502 | 51,502 | 100.00% | 850,813 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.79% | 0.19% | 7,809,852 | - | - | 129,018,755 | Mar 31, 2024 |
| DIAMETRIC CAPITAL, LP | 0.02% | 0.17% | 18,796 | 18,796 | 100.00% | 310,509 | Mar 31, 2024 |
The largest Day One Biopharmaceuticals shareholder by % of total assets is ESTUARY CAPITAL MANAGEMENT LP. The company owns 1.61M shares of Day One Biopharmaceuticals (DAWN), representing 10.81% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAVERICK CAPITAL LTD | 1.58% | 0.39% | 1,256,570 | 1,256,570 | 100.00% | 20,758,536 | Mar 31, 2024 |
| ESTUARY CAPITAL MANAGEMENT LP | 2.02% | 10.81% | 1,611,137 | 728,240 | 82.48% | 26,615,983 | Mar 31, 2024 |
| FMR LLC | 5.52% | 0.00% | 4,404,341 | 436,175 | 10.99% | 72,759,721 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 2.55% | 0.02% | 2,032,384 | 336,281 | 19.83% | 33,574,983 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.90% | 0.12% | 719,011 | 235,772 | 48.79% | 11,878,062 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.23% | 0.00% | 981,572 | 203,655 | 26.18% | 16,215,570 | Mar 31, 2024 |
| ALTITUDE CREST PARTNERS INC. | 0.25% | 1.38% | 195,497 | 195,497 | 100.00% | 3,229,610 | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.21% | 0.00% | 169,522 | 169,522 | 100.00% | 2,800,503 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.09% | 0.00% | 74,154 | 74,154 | 100.00% | 1,225,024 | Mar 31, 2024 |
| CITIGROUP INC | 0.21% | 0.00% | 171,050 | 71,125 | 71.18% | 2,825,746 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.87% | 1.40% | 691,812 | 66,063 | 10.56% | 11,428,734 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.34% | 0.00% | 272,117 | 63,148 | 30.22% | 4,495,373 | Mar 31, 2024 |
| J. GOLDMAN & CO LP | 0.08% | 0.03% | 61,327 | 61,327 | 100.00% | 1,013,122 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.30% | 0.03% | 237,748 | 58,814 | 32.87% | 3,927,596 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.45% | 0.61% | 361,767 | 58,449 | 19.27% | 5,976,391 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.12% | 0.01% | 97,621 | 56,718 | 138.66% | 1,613,000 | Mar 31, 2024 |
| SUMMIT ROCK ADVISORS, LP | 0.06% | 0.27% | 51,502 | 51,502 | 100.00% | 850,813 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.06% | 0.00% | 47,265 | 39,998 | 550.41% | 780,817 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.07% | 0.00% | 53,152 | 37,547 | 240.61% | 878,071 | Mar 31, 2024 |
| UBS GROUP AG | 0.21% | 0.00% | 164,018 | 37,378 | 29.52% | 2,709,577 | Mar 31, 2024 |
As of Mar 31 2024, Day One Biopharmaceuticals's largest institutional buyer is MAVERICK CAPITAL LTD. The company purchased 1.26M stocks of DAWN, valued at $20.76M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | 2.72% | 1.16% | 2,173,704 | -2,041,869 | -48.44% | 35,909,590 | Mar 31, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 8.06% | 9.80% | 6,430,257 | -1,178,137 | -15.48% | 106,227,846 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -1,000,000 | -100.00% | - | Mar 31, 2024 |
| PFM HEALTH SCIENCES, LP | 0.45% | 0.28% | 355,251 | -948,324 | -72.75% | 5,868,747 | Mar 31, 2024 |
| STATE STREET CORP | 3.63% | 0.00% | 2,894,883 | -485,215 | -14.36% | 47,823,467 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 4.77% | 0.02% | 3,806,790 | -430,005 | -10.15% | 62,888,164 | Mar 31, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -390,167 | -100.00% | - | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 1.65% | 3.26% | 1,318,207 | -382,742 | -22.50% | 21,776,780 | Mar 31, 2024 |
| PIER CAPITAL, LLC | - | - | - | -258,685 | -100.00% | - | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.49% | 0.10% | 1,185,000 | -200,000 | -14.44% | 19,576,200 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.98% | 0.04% | 2,375,137 | -196,431 | -7.64% | 39,237,263 | Mar 31, 2024 |
| BARCLAYS PLC | 0.08% | 0.00% | 67,466 | -118,373 | -63.70% | 1,114,000 | Mar 31, 2024 |
| MORGAN STANLEY | 0.29% | 0.00% | 232,550 | -101,889 | -30.47% | 3,841,726 | Mar 31, 2024 |
| BLACKROCK INC. | 6.31% | 0.00% | 5,031,435 | -94,636 | -1.85% | 83,119,306 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -88,000 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -73,887 | -100.00% | - | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -64,692 | -100.00% | - | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.01% | 0.00% | 10,796 | -44,400 | -80.44% | 178,350 | Mar 31, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.24% | 0.01% | 193,224 | -43,123 | -18.25% | 3,192,060 | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -42,500 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Day One Biopharmaceuticals's biggest institutional seller is BRAIDWELL LP. The company sold -2.04M shares of DAWN, valued at $35.91M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAVERICK CAPITAL LTD | 1.58% | 0.39% | 1,256,570 | 1,256,570 | 100.00% | 20,758,536 | Mar 31, 2024 |
| ALTITUDE CREST PARTNERS INC. | 0.25% | 1.38% | 195,497 | 195,497 | 100.00% | 3,229,610 | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.21% | 0.00% | 169,522 | 169,522 | 100.00% | 2,800,503 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.09% | 0.00% | 74,154 | 74,154 | 100.00% | 1,225,024 | Mar 31, 2024 |
| J. GOLDMAN & CO LP | 0.08% | 0.03% | 61,327 | 61,327 | 100.00% | 1,013,122 | Mar 31, 2024 |
| SUMMIT ROCK ADVISORS, LP | 0.06% | 0.27% | 51,502 | 51,502 | 100.00% | 850,813 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.04% | 0.00% | 32,400 | 32,400 | 100.00% | 535,248,000 | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | 0.04% | 0.01% | 32,142 | 32,142 | 100.00% | 530,986 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 0.00% | 30,900 | 30,900 | 100.00% | 510,468 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.03% | 0.05% | 24,042 | 24,042 | 100.00% | 397,174 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.03% | 0.00% | 20,412 | 20,412 | 100.00% | 337,206 | Mar 31, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 0.02% | 0.07% | 19,419 | 19,419 | 100.00% | 320,802 | Mar 31, 2024 |
| DIAMETRIC CAPITAL, LP | 0.02% | 0.17% | 18,796 | 18,796 | 100.00% | 310,509 | Mar 31, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.02% | 0.00% | 18,560 | 18,560 | 100.00% | 306,611 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | 0.00% | 13,935 | 13,935 | 100.00% | 230,000 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.02% | 0.02% | 13,374 | 13,374 | 100.00% | 220,938 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 10,000 | 10,000 | 100.00% | 165,200,000 | Mar 31, 2024 |
| TSFG, LLC | 0.00% | 0.01% | 3,000 | 3,000 | 100.00% | 50,000 | Mar 31, 2024 |
| 0.00% | 0.00% | 2,824 | 2,824 | 100.00% | 46,652 | Mar 31, 2024 | |
| SIMPLEX TRADING, LLC | 0.00% | - | 2,758 | 2,758 | 100.00% | 45,000 | Mar 31, 2024 |
| CONTINUUM ADVISORY, LLC | 0.00% | 0.00% | 1,340 | 1,340 | 100.00% | 21,949,000 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 902 | 902 | 100.00% | 14,901 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.00% | 0.01% | 582 | 582 | 100.00% | 9,615 | Mar 31, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | 0.00% | 35 | 35 | 100.00% | 578 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 12 | 12 | 100.00% | 198 | Mar 31, 2024 |
Day One Biopharmaceuticals's largest new institutional shareholder by number of shares is MAVERICK CAPITAL LTD, purchased 1.26M shares, valued at $20.76M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | - | - | - | -1,000,000 | -100.00% | - | Mar 31, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -390,167 | -100.00% | - | Mar 31, 2024 |
| PIER CAPITAL, LLC | - | - | - | -258,685 | -100.00% | - | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -88,000 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -73,887 | -100.00% | - | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -64,692 | -100.00% | - | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -42,500 | -100.00% | - | Mar 31, 2024 |
| JUPITER ASSET MANAGEMENT LTD | - | - | - | -36,671 | -100.00% | - | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -30,378 | -100.00% | - | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -15,927 | -100.00% | - | Mar 31, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -15,500 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -14,395 | -100.00% | - | Mar 31, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -12,618 | -100.00% | - | Mar 31, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -10,651 | -100.00% | - | Mar 31, 2024 |
| SANDIA INVESTMENT MANAGEMENT LP | - | - | - | -5,980 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -61 | -100.00% | - | Mar 31, 2024 |
Day One Biopharmaceuticals's largest sold out institutional shareholder by shares sold is BAKER BROS. ADVISORS LP, sold -1.00M shares, valued at -, as of undefined.
Day One Biopharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMG FUNDS | 1.22% | 135,900 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.92% | 40,958 | 28,418 | 226.62% | Feb 29, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.18% | 22,400 | - | - | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.10% | 110,000 | - | - | Dec 29, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 41,661 | - | - | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.08% | 1,259,447 | -4,026 | -0.32% | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.07% | 200,635 | - | - | Dec 31, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.07% | 255,035 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.06% | 275,886 | -5,739 | -2.04% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 406,669 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,013,393 | -54,551 | -5.11% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.03% | 287,384 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,631 | 447 | 4.87% | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 93,175 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 114,600 | 7,238 | 6.74% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 46,502 | 744 | 1.63% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,977,596 | 974,696 | 24.35% | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.01% | 901,833 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 607,633 | 159,900 | 35.71% | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 14,130 | - | - | Dec 31, 2023 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 58,422 | 1,903 | 3.37% | Dec 29, 2023 |
| ALPS ETF Trust | 0.01% | 64,439 | 3,008 | 4.90% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 5,754 | -1,585 | -21.60% | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 28,524 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 731 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 26,040 | 12,265 | 89.04% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 553,158 | -702 | -0.13% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,279 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 290,969 | 10,047 | 3.58% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 226,929 | 40,808 | 21.93% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 40,860 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.00% | 400,350 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 16,078 | - | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 158,900 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 25,486 | 298 | 1.18% | Dec 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 9,741 | -800 | -7.59% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 48,037 | -8,571 | -15.14% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 73,528 | 40,755 | 124.36% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 321,205 | 53,020 | 19.77% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 11,849 | 1,898 | 19.07% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 162,524 | 14,871 | 10.07% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,961 | -340 | -10.30% | Dec 31, 2023 |
| BlackRock ETF Trust | 0.00% | 404 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 376,387 | 242,729 | 181.60% | Jan 31, 2024 |
| Dunham Funds | 0.00% | 24,996 | 24,996 | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 337,665 | -30,240 | -8.22% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 722 | -5,656 | -88.68% | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 997 | -1,283 | -56.27% | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 21,400 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,950 | -358 | -10.82% | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 170,262 | 15,362 | 9.92% | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 287,075 | 35,552 | 14.13% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 569 | - | - | Dec 31, 2023 |
| Trust for Advised Portfolios | 0.00% | 2,567 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 17,343 | 9,917 | 133.54% | Dec 31, 2023 |
| VALIC Co I | 0.00% | 24,044 | -97 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,300 | - | - | Dec 29, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 9,523 | -352 | -3.56% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 282 | - | - | Dec 31, 2023 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 977 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 15,684 | 2,040 | 14.95% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 2,108,949 | 206,253 | 10.84% | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,270 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 4,108 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 1,214 | -77 | -5.96% | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 34,057 | -1,040 | -2.96% | Dec 29, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 81,970 | 2,200 | 2.76% | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 37 | - | - | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 95,000 | - | - | Dec 31, 2023 |
| Pacer Funds Trust | 0.00% | 1,292 | -894 | -40.90% | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 57,643 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 10,372 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,325 | - | - | Feb 29, 2024 |
| TRANSAMERICA SERIES TRUST | 0.00% | 20,533 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 7,098 | -29 | -0.41% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 122 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 36,628 | -538 | -1.45% | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 178 | -72,221 | -99.75% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 11,974 | - | - | Dec 31, 2023 |
| EMPOWER FUNDS, INC. | 0.00% | 12,327 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,328 | 804 | 52.76% | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 21,024 | 257 | 1.24% | Dec 31, 2023 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 14,368 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,857 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 58,051 | -2,834,500 | -97.99% | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 12,634 | 470 | 3.86% | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 7,776 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 17,360 | 1,660 | 10.57% | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 242 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 6,468 | -7,842 | -54.80% | Feb 29, 2024 |
Day One Biopharmaceuticals's largest mutual fund holder by % of total assets is "AMG FUNDS", owning 135.90K shares, compromising 1.22% of its total assets.
Day One Biopharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 55 | -59.26% |
| 31 Dec, 23 | 135 | 8.00% |
| 30 Sep, 23 | 125 | -9.42% |
| 30 Jun, 23 | 138 | 13.11% |
| 31 Mar, 23 | 122 | 14.02% |
| 31 Dec, 22 | 107 | 20.22% |
| 30 Sep, 22 | 89 | - |
| 30 Jun, 22 | 89 | 36.92% |
| 31 Mar, 22 | 65 | 14.04% |
| 31 Dec, 21 | 57 | 26.67% |
| 30 Sep, 21 | 45 | 40.63% |
| 30 Jun, 21 | 32 | - |
As of 31 Mar 24, 55 institutions are holding Day One Biopharmaceuticals's shares, representing a decrease of -59.26% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 22,478,030 | -70.60% |
| 31 Dec, 23 | 76,449,174 | -1.06% |
| 30 Sep, 23 | 77,271,031 | -1.69% |
| 30 Jun, 23 | 78,597,055 | 29.09% |
| 31 Mar, 23 | 60,886,196 | 1.12% |
| 31 Dec, 22 | 60,213,794 | -0.83% |
| 30 Sep, 22 | 60,715,434 | 2.25% |
| 30 Jun, 22 | 59,382,173 | 37.19% |
| 31 Mar, 22 | 43,283,880 | 4.36% |
| 31 Dec, 21 | 41,477,324 | 117.20% |
| 30 Sep, 21 | 19,096,040 | 7.74% |
| 30 Jun, 21 | 17,724,839 | - |
Day One Biopharmaceuticals (DAWN) has 22.48M shares outstanding as of 31 Mar 24, down -70.60% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 28.18% | 0.36% |
| 31 Dec, 23 | 88.94% | 0.84% |
| 30 Sep, 23 | 103.08% | 0.86% |
| 30 Jun, 23 | 109.20% | 1.53% |
| 31 Mar, 23 | 84.60% | 1.00% |
| 31 Dec, 22 | 91.98% | 1.26% |
| 30 Sep, 22 | 85.50% | 0.90% |
| 30 Jun, 22 | 97.73% | 1.78% |
| 31 Mar, 22 | 74.14% | 0.59% |
| 31 Dec, 21 | 112.22% | 4.20% |
| 30 Sep, 21 | 51.67% | 0.84% |
| 30 Jun, 21 | 78.21% | - |
As of 31 Mar 24, Day One Biopharmaceuticals is held by 28.18% institutional shareholders, representing a 0.36% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 26 | -65.33% |
| 31 Dec, 23 | 75 | 11.94% |
| 30 Sep, 23 | 67 | -31.63% |
| 30 Jun, 23 | 98 | 46.27% |
| 31 Mar, 23 | 67 | 6.35% |
| 31 Dec, 22 | 63 | 12.50% |
| 30 Sep, 22 | 56 | -9.68% |
| 30 Jun, 22 | 62 | 63.16% |
| 31 Mar, 22 | 38 | -9.52% |
| 31 Dec, 21 | 42 | 31.25% |
| 30 Sep, 21 | 32 | - |
| 30 Jun, 21 | 32 | - |
26 institutional shareholders have increased their position in DAWN stock as of 31 Mar 24 compared to 75 in the previous quarter (a -65.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 18 | -45.45% |
| 31 Dec, 23 | 33 | - |
| 30 Sep, 23 | 33 | 50.00% |
| 30 Jun, 23 | 22 | -24.14% |
| 31 Mar, 23 | 29 | 26.09% |
| 31 Dec, 22 | 23 | 27.78% |
| 30 Sep, 22 | 18 | 20.00% |
| 30 Jun, 22 | 15 | 25.00% |
| 31 Mar, 22 | 12 | 140.00% |
| 31 Dec, 21 | 5 | -28.57% |
| 30 Sep, 21 | 7 | - |
| 30 Jun, 21 | - | - |
18 institutional shareholders have reduced their position in DAWN stock as of 31 Mar 24 compared to 33 in the previous quarter (a -45.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 55 | -59.26% | 22,478,030 | -70.60% | 28.18% | 0.36% | 26 | -65.33% | 18 | -45.45% |
| 31 Dec, 23 | 135 | 8.00% | 76,449,174 | -1.06% | 88.94% | 0.84% | 75 | 11.94% | 33 | - |
| 30 Sep, 23 | 125 | -9.42% | 77,271,031 | -1.69% | 103.08% | 0.86% | 67 | -31.63% | 33 | 50.00% |
| 30 Jun, 23 | 138 | 13.11% | 78,597,055 | 29.09% | 109.20% | 1.53% | 98 | 46.27% | 22 | -24.14% |
| 31 Mar, 23 | 122 | 14.02% | 60,886,196 | 1.12% | 84.60% | 1.00% | 67 | 6.35% | 29 | 26.09% |
| 31 Dec, 22 | 107 | 20.22% | 60,213,794 | -0.83% | 91.98% | 1.26% | 63 | 12.50% | 23 | 27.78% |
| 30 Sep, 22 | 89 | - | 60,715,434 | 2.25% | 85.50% | 0.90% | 56 | -9.68% | 18 | 20.00% |
| 30 Jun, 22 | 89 | 36.92% | 59,382,173 | 37.19% | 97.73% | 1.78% | 62 | 63.16% | 15 | 25.00% |
| 31 Mar, 22 | 65 | 14.04% | 43,283,880 | 4.36% | 74.14% | 0.59% | 38 | -9.52% | 12 | 140.00% |
| 31 Dec, 21 | 57 | 26.67% | 41,477,324 | 117.20% | 112.22% | 4.20% | 42 | 31.25% | 5 | -28.57% |
| 30 Sep, 21 | 45 | 40.63% | 19,096,040 | 7.74% | 51.67% | 0.84% | 32 | - | 7 | - |
| 30 Jun, 21 | 32 | - | 17,724,839 | - | 78.21% | - | 32 | - | - | - |
Day One Biopharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Day One Biopharmaceuticals's stock was made by Bender Jeremy on May 17 2024, selling 7,873 shares at $16.08 per share (valued at $126.59K).
Day One Biopharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 12 | 24 | 50.00% |
| Q1 2024 | 22 | 19 | 115.79% |
| Q4 2023 | 11 | 16 | 68.75% |
| Q3 2023 | 10 | 14 | 71.43% |
| Q2 2023 | 14 | 10 | 140.00% |
| Q1 2023 | 12 | 22 | 54.55% |
| Q4 2022 | 3 | 29 | 10.34% |
| Q3 2022 | 3 | 62 | 4.84% |
| Q2 2022 | 16 | 1 | 1600.00% |
| Q1 2022 | 9 | 2 | 450.00% |
| Q4 2021 | 2 | 12 | 16.67% |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 17 | 31 | 54.84% |
| Q1 2021 | 2 | - | - |
12 total buy trades, and 24 total sell trades (buy/sell ratio of 0.50%) were made by Day One Biopharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 12 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | 3 | 4 | 75.00% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 1 | 4 | 25.00% |
| Q1 2023 | - | 16 | - |
| Q4 2022 | - | 25 | - |
| Q3 2022 | - | 55 | - |
| Q2 2022 | 5 | 1 | 500.00% |
| Q1 2022 | 3 | 2 | 150.00% |
| Q4 2021 | - | 8 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 1 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 12 open market sell trades of Day One Biopharmaceuticals's stocks.
DAWN Ownership FAQ
Who Owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals is owned by institutional shareholders (28.18%), insiders (19.65%), and public (52.18%). The largest institutional shareholder of Day One Biopharmaceuticals is RA CAPITAL MANAGEMENT, L.P. (9.79% of total shares) and the top mutual fund owner is AMG FUNDS (1.22% of total shares).
Who are the major institutional shareholders of Day One Biopharmaceuticals?
Day One Biopharmaceuticals's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, BLACKROCK INC., VANGUARD GROUP INC, and FMR LLC. The top five shareholders own together 35.66% of the company's share outstanding.
How many Day One Biopharmaceuticals shareholders are there?
As of Mar 2024, there are 55 institutional shareholders of Day One Biopharmaceuticals.
What percentage of Day One Biopharmaceuticals is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 7.81M shares of Day One Biopharmaceuticals, representing 9.79% of the company's total shares outstanding, valued at $129.02M (as of Mar 2024).
What percentage of Day One Biopharmaceuticals is owned by ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?
As of Mar 2024, ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC holds 6.43M shares of Day One Biopharmaceuticals (DAWN), compromising 8.06% of the company, valued at $106.23M.
What percentage of Day One Biopharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Day One Biopharmaceuticals. The company owns 5.03M of the company's shares outstanding (worth $83.12M).